Bioactive Materials

Bioactive Materials

Volume 8, February 2022, Pages 20-34
Bioactive Materials

Overcoming the obstacles of current photodynamic therapy in tumors using nanoparticles

https://doi.org/10.1016/j.bioactmat.2021.06.019Get rights and content
Under a Creative Commons license
open access

Highlights

  • Successful photodynamic therapy in tumors has been inhibited by obstacles including insufficient amount of photosensitizer, light attenuation, and unfavorable tumor microenvironmrnt.

  • Until now, various nanoparticles have been developed and used for tumor-targeted photodynamic therapy.

  • The nanpparticles showed potential to overcome the obstacles by efficient supply of photosensitizers, light, and oxygen.

Abstract

Photodynamic therapy (PDT) has been applied in clinical treatment of tumors for a long time. However, insufficient supply of pivotal factors including photosensitizer (PS), light, and oxygen in tumor tissue dramatically reduces the therapeutic efficacy of PDT. Nanoparticles have received an influx of attention as drug carriers, and recent studies have demonstrated their promising potential to overcome the obstacles of PDT in tumor tissue. Physicochemical optimization for passive targeting, ligand modification for active targeting, and stimuli-responsive release achieved efficient delivery of PS to tumor tissue. Various trials using upconversion NPs, two-photon lasers, X-rays, and bioluminescence have provided clues for efficient methods of light delivery to deep tissue. Attempts have been made to overcome unfavorable tumor microenvironments via artificial oxygen generation, Fenton reaction, and combination with other chemical drugs. In this review, we introduce these creative approaches to addressing the hurdles facing PDT in tumors. In particular, the studies that have been validated in animal experiments are preferred in this review over proof-of-concept studies that were only performed in cells.

Keywords

Photodynamic therapy
Nanoparticle
Tumor-targeting
Drug delivery
Tissue penetration

Cited by (0)

Peer review under responsibility of KeAi Communications Co., Ltd.